International Journal of Stem Cells : eISSN 2005-5447

Fig. 2.

Download original image
Fig. 2. FLT-4 expressions on AML-NK cells in vitro. (A) CD56CD3 lymphocytes are considered NK cells, and AML characterization has been based on multi-parameter analyses. IFN-γ positive NK cells are detected from AML samples. (B) FACS data of single-, double-/triple treatment groups in AML BM. (C) FACS data of single-, double/triple treatment groups in AML PB. Data shown represent the means of independent experiment. Asterisks depict statistically significant differences compared to AML patient (*p <0.05 vs. AML patients, In BM, 13 AML patients; In PB; 11 AML patients). AML: AML patient, P: peptide, M: MAZ51, A: ara-C.
International Journal of Stem Cells 2021;14:400-9 https://doi.org/10.15283/ijsc21083
© 2021 International Journal of Stem Cells